Exhaustion of endothelial reparation as factor of atherosclerosis progression

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Atherosclerosis is a polyetiologic disease. Atherogenicdysli poproteinemiahas the greatest role in atherogenesis, but there are a lot of atherogenic factors independent of lipid profile. Contemporary scientific data underline the key importance of endothelial reparation in protection of endothelium from detrimental influences (smoking, dyslipoproteinemia, diabetes etc.).

About the authors

YSh. Sh Khalimov

S.M. Kirov Military Medical Academy, Saint-Petersburg

A. V Babak

S.M. Kirov Military Medical Academy, Saint-Petersburg

V. V Zatcepin

S.M. Kirov Military Medical Academy, Saint-Petersburg

O. V Vetryakov

S.M. Kirov Military Medical Academy, Saint-Petersburg

G. A Tcepkova

S.M. Kirov Military Medical Academy, Saint-Petersburg

References

  1. Константинов В.О. Доклинический атеросклероз [диагностика и лечение). СПб.: ИНкАРт; 2006.
  2. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation2000; 101(16): 1899-906.
  3. Suwaidi J.A., Hamasaki S., Higano S.T. et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.Circulation 2000; 101(9): 948-54.
  4. Петрищев H.H., Власов Т.Д. Физиология и патофизиология эндотелия. В: Н.Н. Петрищева, редактор. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция.под ред. СПб.: Изд-во СПбГМУ; 2003. С. 4-38.
  5. Szmitko P.E., Wang C.H., Weisel R.D. et al. Biomarkers of vascular disease linking inflammation to endothelial activation part II (Special Review). Circulation 2003; 108(7): 2041-8.
  6. Werner N., Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis.J. Cell. Mol. Med. 2006; 10(2); 318-32.
  7. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. Eur. Heart J. 1997; 18: E19-E29.
  8. Nagornev V.A., Rabinovich V.S. Can endothelial cells accumulate lipids? Atherosclerosis 1998; 136(1): 197-8.
  9. Ashahara T., Murohara T., Sillivan A. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275(5302): 964-7.
  10. Hirschi K., Goodell M. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Therapy 2002; 9(10): 648-52.
  11. Wagers A., Weissman I. Plasticity of аdult stem cells. Cell 2004; 116(5): 639-48.
  12. Orlic D. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410(2525): 701-5.
  13. Agbulut O., Vandervelde S., Al Attar N. et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J. Am. Coll. Cardiol. 2004; 44(2): 458-63.
  14. Stamm C., Kleine H.D., Westphal B. et al. CABG and bone marrow stem cell transplantation after myocardium infarction.Thorac. Cardiovasc. Surg. 2004; 52(3): 152-8.
  15. Kang H.J., Lee H.Y., Na S.H. et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006; 114(Suppl. 1): I145-I51.
  16. Terada N. et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416(6880): 542-45.
  17. Ying Q., Nichols J., Evans E.P. et al. Changing potency by spontaneous fusion. Nature 2002; 416(6880): 545-8.
  18. Шутко А.Н. Метаболические и функциональные аспекты взаимодействия внеклеточной ДНК с лимфоидными клетками облученного организма [диссертация]. - Л.; 1985.
  19. Kinnaird T., Stabile E., Burnett M.S. et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109(21): 1543-49.
  20. Ziegelhoeffer T., Fernandez B., Kostin S. et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 2004; 94(2): 230-8.
  21. De Groot K., Goldberg C., Bahlmann F.H. et al. Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatism 2007; 56(11): 3847-53.
  22. Yin A.H., Miraglia S., Zanjani E.D. et al. AC 133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90(12): 5002-12.
  23. Gehling U.M., Ergun S., Schumacher U. et al. In vitro differentiation of endothelial cells from AC 133-positive progenitor cells. Blood 2000; 95(10): 3106-12.
  24. Peichev M., Naiyer A.J., Pereira D. et al. Expression of VEGFR-2 and AC133 by circulating human CD34(-) cells identifies a population of functional endothelial precursors. Blood 2000; 95(3): 952-8.
  25. Gill M., Dias S., Hattori K. et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+) AC133(+) endothelial precursor cells. Circ. Res. 2001; 88(2): 167-74.
  26. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004; 95(4): 343-53.
  27. Paxinos G., Katritsis D. Autologous stem cell transplantation for regeneration of infarcted myocardium: clinical trials. Hellenic J. Cardiol. 2008; 49(3): 163-8.
  28. Hristov M., Erl W., Weber P. Endothelial progenitor cells mobilization, differentiation, and homing. Arterioscler. Thromb. Vas^ Biol. 2003; 23(7): 1185-9.
  29. Schwartz S.M., Benditt E.P. Clustering of replicating cells in aortic endothelium. PNAS USA 1976; 73(2): 651-3.
  30. Akar A., Durdu S., Deniz G. et al. Failing heart: remodel, replace or repair. Anadolu. Cardiol. Derg. 200; 8(Suppl. 2): 148-57.
  31. Zavada J., Kideryova L., Pytlik R. et al. Circulating endothelial cells and circulating endothelial progenitors in kidney disease - victims, witnesses or accomplices? Folia Biologica (Praha) 2008; 54(3): 73-80.
  32. Vasa M., Fichtlscherer S., Adler K. et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103(24): 2885-90.
  33. George J., Herz I., Goldstein E. et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis.Arterioscler. Thromb. Vasc. Biol. 2003; 23(12): e57-e60.
  34. Tepper O.M., Galiano R.D., Capla J.M. et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.Circulation 2002; 106(22): 2781-86.
  35. Ghani U., Shuaib A., Salam A. et al. Endothelial progenitor cells during cerebrovascular disease.Stroke 2005; 36(1): 151-3.
  36. Grisar J., Aletaha D., Steiner C.W. et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005; 111(2): 204-11.
  37. Suh W., Kim K.L., Choi J.H. et al. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells.Biochem. Biophys. Res. Commun. 2004; 321(1): 65-71.
  38. Sturiale A., Coppolino G., Loddo S. et. al. Effects of haemodialysis on circulating endothelial progenitor cell count.Blood Purif. 2007; 25(3): 242-51.
  39. Kuwana M., Okazaki Y., Yasuoka H. et al. Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364(9434): 603-10.
  40. Yamada M., Kubo H., Ishizawa K. et al. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax 2005; 60(5): 410-3.
  41. Hill J.M., Zalos G., Halcox J.P.J. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003; 348(7): 593-600.
  42. Chen J.Z., Zhang F.R., Tao Q.M. et al. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin. Sci. 2004;107(3): 273-80.
  43. Kondo T., Hayashi M., Takeshita K. et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers.Arterioscler. Thromb. Vasc. Biol. 2004; 24(8): 1442-7.
  44. Verma S., Kuliszewski M.A., Li S.H. et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109(17): 2058-67.
  45. Rauscher M., Goldschmidt-Clermont P., Bryce H. et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108(4): 457-63.
  46. Laufs U., Werner N., Link A. et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis.Circulation 2004;109(2): 220-6.
  47. Sandri M., Adams V., Gielen S. et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 2005; 111(25): 3391-9.
  48. Llevadot J., Murasawa S., Kureishi Y. et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 2001; 108(3): 399-405.
  49. Landmesser U., Hornig B., Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation 2004; 109(21): II27-II33.
  50. Min T.Q., Zhu C.J., Xiang W.X. et al. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 2004; 18(3): 203-9.
  51. Balhmann F.H., De Groot K., Mueller O. et al. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hipertension 2005; 45(4): 526-9.
  52. Strehlow K., Werner N., Berweiler J. et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation2003; 107(24): 3059-65.
  53. Schmidt-LuckeC., Rossig L., Fichtlscherer S. et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111(22): 2981-7.
  54. Zhang M., Zhou S.H., Li X.P. et al. A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury. Med. Hypotheses. 2008; 70(4): 838-41.
  55. Kravchenko J., Goldschmidt-Clermont P.J., Powell T. et al. Endothelial progenitor cell therapy for atherosclerosis: the philosopher's stone for an aging population?Sci. Aging Knowledge Environ. 2005; 25: e18.
  56. George J., Goldstein E., Abashidze S. et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur. Heart J.2004; 25(12): 1003-8.
  57. Kaminsky M., Majewski S., Kaminska G. et al. Enhancing effect of X-ray irradiation on a new blood vessel formation in mice tested by lymphocyte induced angiogenesis assay. Arch. Immunol. and therapy exper.1978; 26(1-6): 1075-8.
  58. Бабаева А.Г. О роли гуморальных и клеточных факторов иммунитета в регуляции процессов восстановления внутренних органов у позвоночных. Восстановительные и пролиферативные процессы у животных. М.: Наука; 1969. C. 66-82.
  59. Бабаева А.Г., Краскина Н.А., Лиознер Л.Д. Влияние лимфоидных клеток односторонне нефрэктомированных мышей на пролиферативную активность почек и печенинеоперированных реципиентов. Бюл. эксперим. биол. мед. 1973; 75(2): 78-80.
  60. Бабаева А.Г. Регенерация и система иммуногенеза. М.: Медицина; 1985.
  61. Бабаева А.Г., Зотиков Е.А. Иммунология процессов адаптивного роста, пролиферации и их нарушений. М.: Наука; 1987.
  62. Шутко А.Н., Шатинина Н.Н., Теренхов И.Л. Лимфоциты стерминальной дезоксинуклеотидилтрансферазой в пролиферативном ответе. Вопросы экспериментальной и клинической рентгено-радиологии. Л.; 1991. С. 56-61.
  63. Ashahara T., Masuda H., Takahashi T. et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999; 85(3): 221-8.
  64. Xu Q., Zhang Z., Davison F. et al. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ. Res.2003l; 93(8): e76-e86.
  65. Rumpold H., Wolf D., Koeck R. et al. Endothelial progenitor cells: a source for therapeutic vasculogenesis? J. Cell. Mol. Med. 2004; 8(4): 509-18.
  66. Roberts N., Jahangiri M., Xu Q. Progenitor cells in vascular disease. J. Cell Mol. Med. 2005; 9(3): 583-91.
  67. Mostafa L., Jones D., Wright D. Mechanisms of the induction of angiogenesis by human neoplastic lymphoid tissue. J. Pathol. 1980; 132(2): 191-205.
  68. Suvarnamani C., Halperin E., Proia A. et al. The effects of total lymphoid irradiation upon corneal vascularisation in the rat following chemical cautery. Radiat. Res. 1989; 117(2): 259-72.
  69. Folkman J. Angiogenesis in cancer vascular, rheumatoid and other disease. Nat. Med. 1995; 1(1): 27-31.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies